China Plague Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Plague is an infectious disease caused by the bacterium Yersinia pestis. Symptoms include fever, weakness and headache. Usually this begins one to seven days after exposure. In the bubonic form there is also swelling of lymph nodes, while in the septicemic form tissues may turn black and die, and in the pneumonic form shortness of breath, cough and chest pain may occur.Antibiotics and supportive therapy are effective against plague if patients are diagnosed in time. Pneumonic plague can be fatal within 18 to 24 hours of disease onset if left untreated, but common antibiotics for enterobacteria (gram negative rods) can effectively cure the disease if they are delivered early.

    This report elaborates on the current development of the Plague industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Abbott

    • Exoxemis

    • Eli Lilly

    • Bayer HealthCare

    • Merck

    • Aurobindo Pharma

    • Allergan

    • Actelion Pharmaceuticals

    • Pfizer

    • Baxter

    • Basilea Pharmaceutica

    • Astellas Pharma

    • Aspen Pharmacare

    • Bristol-Myers Squibb

    • AstraZeneca

    • Cipher Pharmaceuticals

    • Chiesi Farmaceutici

    • CordenPharma

    • GlaxoSmithKline

    • Cempra

    By Type:

    • Gentamycin

    • Streptomycin

    • Other Antibiotics

    By Application:

    • Clinics

    • Others

    • Hospitals

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Plague Market Overview 2018-2029

    • 1.1 China Plague Industry Development Overview

    • 1.2 China Plague Industry Development History

    • 1.3 China Plague Industry Market Size (2018-2029)

    • 1.4 China Plague Market Analysis by Type from Production Side

      • 1.4.1 China Plague Production Volume, Production Value and Growth Rate of Gentamycin (2018-2029)

      • 1.4.2 China Plague Production Volume, Production Value and Growth Rate of Streptomycin (2018-2029)

      • 1.4.3 China Plague Production Volume, Production Value and Growth Rate of Other Antibiotics (2018-2029)

    • 1.5 China Plague Market Analysis by Application from Consumption End

      • 1.5.1 China Plague Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

      • 1.5.2 China Plague Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.3 China Plague Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • 1.6 China Plague Market Analysis by Region

      • 1.6.1 North China Plague Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Plague Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Plague Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Plague Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Plague Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Plague Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Plague Market Size and Growth Rate from 2018-2029

    Chapter 2 China Plague Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Plague Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Plague Market Status and Competition Analysis in 2023

      • 2.2.3 China Plague Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Plague Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Plague Industry Development

    Chapter 3 PlagueIndustry Chain Analysis

    • 3.1 Plague Industry Chain

    • 3.2 Plague Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Plague Market

    • 3.3 Plague Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Plague Market

    Chapter 4 China Plague Market, by Type

    • 4.1 China Plague Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Plague Total Production Volume and Growth Rate from Production Side

    • 4.5 China Plague Production Volume and Growth Rate, by Type

      • 4.5.1 China Plague Production Volume and Growth Rate of Gentamycin

      • 4.5.2 China Plague Production Volume and Growth Rate of Streptomycin

      • 4.5.3 China Plague Production Volume and Growth Rate of Other Antibiotics

    Chapter 5 China Plague Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Plague Total Market Size and Growth Rate from Consumption End

    • 5.5 China Plague Market Size and Growth Rate, by Application

      • 5.5.1 China Plague Market Size and Growth Rate of Clinics

      • 5.5.2 China Plague Market Size and Growth Rate of Others

      • 5.5.3 China Plague Market Size and Growth Rate of Hospitals

    Chapter 6 China Plague Market, by Region

    • 6.1 China Plague Production Volume and Production Value, by Region

    • 6.2 China Plague Sales Volume and Sales Value, by Region

    Chapter 7 North China Plague Market Analysis

    • 7.1 North China Plague Market, by Type

    • 7.2 North China Plague Market, by Application

    Chapter 8 Central China Plague Market Analysis

    • 8.1 Central China Plague Market, by Type

    • 8.2 Central China Plague Market, by Application

    Chapter 9 South China Plague Market Analysis

    • 9.1 South China Plague Market, by Type

    • 9.2 South China Plague Market, by Application

    Chapter 10 East China Plague Market Analysis

    • 10.1 East China Plague Market, by Type

    • 10.2 East China Plague Market, by Application

    Chapter 11 Northeast China Plague Market Analysis

    • 11.1 Northeast China Plague Market, by Type

    • 11.2 Northeast China Plague Market, by Application

    Chapter 12 Southwest China Plague Market Analysis

    • 12.1 Southwest China Plague Market, by Type

    • 12.2 Southwest China Plague Market, by Application

    Chapter 13 Northwest China Plague Market Analysis

    • 13.1 Northwest China Plague Market, by Type

    • 13.2 Northwest China Plague Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Abbott

        • 14.1.1 Abbott Company Profile

        • 14.1.2 Abbott Plague Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Exoxemis

        • 14.2.1 Exoxemis Company Profile

        • 14.2.2 Exoxemis Plague Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Eli Lilly

        • 14.3.1 Eli Lilly Company Profile

        • 14.3.2 Eli Lilly Plague Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Bayer HealthCare

        • 14.4.1 Bayer HealthCare Company Profile

        • 14.4.2 Bayer HealthCare Plague Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Merck

        • 14.5.1 Merck Company Profile

        • 14.5.2 Merck Plague Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Aurobindo Pharma

        • 14.6.1 Aurobindo Pharma Company Profile

        • 14.6.2 Aurobindo Pharma Plague Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Allergan

        • 14.7.1 Allergan Company Profile

        • 14.7.2 Allergan Plague Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Actelion Pharmaceuticals

        • 14.8.1 Actelion Pharmaceuticals Company Profile

        • 14.8.2 Actelion Pharmaceuticals Plague Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Pfizer

        • 14.9.1 Pfizer Company Profile

        • 14.9.2 Pfizer Plague Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Baxter

        • 14.10.1 Baxter Company Profile

        • 14.10.2 Baxter Plague Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Basilea Pharmaceutica

        • 14.11.1 Basilea Pharmaceutica Company Profile

        • 14.11.2 Basilea Pharmaceutica Plague Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Astellas Pharma

        • 14.12.1 Astellas Pharma Company Profile

        • 14.12.2 Astellas Pharma Plague Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Aspen Pharmacare

        • 14.13.1 Aspen Pharmacare Company Profile

        • 14.13.2 Aspen Pharmacare Plague Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Bristol-Myers Squibb

        • 14.14.1 Bristol-Myers Squibb Company Profile

        • 14.14.2 Bristol-Myers Squibb Plague Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 AstraZeneca

        • 14.15.1 AstraZeneca Company Profile

        • 14.15.2 AstraZeneca Plague Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Cipher Pharmaceuticals

        • 14.16.1 Cipher Pharmaceuticals Company Profile

        • 14.16.2 Cipher Pharmaceuticals Plague Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Chiesi Farmaceutici

        • 14.17.1 Chiesi Farmaceutici Company Profile

        • 14.17.2 Chiesi Farmaceutici Plague Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 CordenPharma

        • 14.18.1 CordenPharma Company Profile

        • 14.18.2 CordenPharma Plague Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 GlaxoSmithKline

        • 14.19.1 GlaxoSmithKline Company Profile

        • 14.19.2 GlaxoSmithKline Plague Market Performance

        • 14.19.3 Product&Service Introduction

      • 14.20 Cempra

        • 14.20.1 Cempra Company Profile

        • 14.20.2 Cempra Plague Market Performance

        • 14.20.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Plague Industry Research Conclusions

    • 15.2 Plague Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Plague Industry Market Size (2018-2029)

    • Figure China Plague Production Volume, Production Value and Growth Rate of Gentamycin (2018-2029)

    • Figure China Plague Production Volume, Production Value and Growth Rate of Streptomycin (2018-2029)

    • Figure China Plague Production Volume, Production Value and Growth Rate of Other Antibiotics (2018-2029)

    • Figure China Plague Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

    • Figure China Plague Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Plague Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure North China Plague Market Size and Growth Rate from 2018-2029

    • Figure Central China Plague Market Size and Growth Rate from 2018-2029

    • Figure South China Plague Market Size and Growth Rate from 2018-2029

    • Figure East China Plague Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Plague Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Plague Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Plague Market Size and Growth Rate from 2018-2029

    • Figure Plague Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Plague Market Share by Type in 2018

    • Figure China Plague Market Share by Type in 2023

    • Figure China Plague Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Plague Production Volume and Growth Rate of Gentamycin (2018-2023)

    • Figure China Plague Production Volume and Growth Rate of Streptomycin (2018-2023)

    • Figure China Plague Production Volume and Growth Rate of Other Antibiotics (2018-2023)

    • Figure China Plague Market Share by Application in 2018

    • Figure China Plague Market Share by Application in 2023

    • Figure China Plague Total Market Size and Growth Rate from Consumption End

    • Figure China Plague Market Size and Growth Rate of Clinics (2018-2023)

    • Figure China Plague Market Size and Growth Rate of Others (2018-2023)

    • Figure China Plague Market Size and Growth Rate of Hospitals (2018-2023)

    • Table China Plague Production Volume by Region (2018-2023)

    • Table China Plague Production Volume Share by Region (2018-2023)

    • Figure China Plague Production Volume Share by Region (2018-2023)

    • Table China Plague Production Value by Region (2018-2023)

    • Table China Plague Production Value Share by Region (2018-2023)

    • Figure China Plague Production Value Share by Region (2018-2023)

    • Table China Plague Sales Volume by Region (2018-2023)

    • Table China Plague Sales Volume Share by Region (2018-2023)

    • Figure China Plague Sales Volume Share by Region (2018-2023)

    • Table China Plague Sales Value by Region (2018-2023)

    • Table China Plague Sales Value Share by Region (2018-2023)

    • Figure China Plague Sales Value Share by Region (2018-2023)

    • Table North China Plague Production Volume by Type (2018-2023)

    • Table North China Plague Production Volume Share by Type (2018-2023)

    • Figure North China Plague Production Volume Share by Type (2018-2023)

    • Table North China Plague Sales Volume by Application (2018-2023)

    • Table North China Plague Sales Volume Share by Application (2018-2023)

    • Figure North China Plague Sales Volume Share by Application (2018-2023)

    • Table Central China Plague Production Volume by Type (2018-2023)

    • Table Central China Plague Production Volume Share by Type (2018-2023)

    • Figure Central China Plague Production Volume Share by Type (2018-2023)

    • Table Central China Plague Sales Volume by Application (2018-2023)

    • Table Central China Plague Sales Volume Share by Application (2018-2023)

    • Figure Central China Plague Sales Volume Share by Application (2018-2023)

    • Table South China Plague Production Volume by Type (2018-2023)

    • Table South China Plague Production Volume Share by Type (2018-2023)

    • Figure South China Plague Production Volume Share by Type (2018-2023)

    • Table South China Plague Sales Volume by Application (2018-2023)

    • Table South China Plague Sales Volume Share by Application (2018-2023)

    • Figure South China Plague Sales Volume Share by Application (2018-2023)

    • Table East China Plague Production Volume by Type (2018-2023)

    • Table East China Plague Production Volume Share by Type (2018-2023)

    • Figure East China Plague Production Volume Share by Type (2018-2023)

    • Table East China Plague Sales Volume by Application (2018-2023)

    • Table East China Plague Sales Volume Share by Application (2018-2023)

    • Figure East China Plague Sales Volume Share by Application (2018-2023)

    • Table Northeast China Plague Production Volume by Type (2018-2023)

    • Table Northeast China Plague Production Volume Share by Type (2018-2023)

    • Figure Northeast China Plague Production Volume Share by Type (2018-2023)

    • Table Northeast China Plague Sales Volume by Application (2018-2023)

    • Table Northeast China Plague Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Plague Sales Volume Share by Application (2018-2023)

    • Table Southwest China Plague Production Volume by Type (2018-2023)

    • Table Southwest China Plague Production Volume Share by Type (2018-2023)

    • Figure Southwest China Plague Production Volume Share by Type (2018-2023)

    • Table Southwest China Plague Sales Volume by Application (2018-2023)

    • Table Southwest China Plague Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Plague Sales Volume Share by Application (2018-2023)

    • Table Northwest China Plague Production Volume by Type (2018-2023)

    • Table Northwest China Plague Production Volume Share by Type (2018-2023)

    • Figure Northwest China Plague Production Volume Share by Type (2018-2023)

    • Table Northwest China Plague Sales Volume by Application (2018-2023)

    • Table Northwest China Plague Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Plague Sales Volume Share by Application (2018-2023)

    • Table Abbott Company Profile

    • Table Abbott Plague Revenue, Price and Gross (2018-2023)

    • Table Exoxemis Company Profile

    • Table Exoxemis Plague Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Plague Revenue, Price and Gross (2018-2023)

    • Table Bayer HealthCare Company Profile

    • Table Bayer HealthCare Plague Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Plague Revenue, Price and Gross (2018-2023)

    • Table Aurobindo Pharma Company Profile

    • Table Aurobindo Pharma Plague Revenue, Price and Gross (2018-2023)

    • Table Allergan Company Profile

    • Table Allergan Plague Revenue, Price and Gross (2018-2023)

    • Table Actelion Pharmaceuticals Company Profile

    • Table Actelion Pharmaceuticals Plague Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Plague Revenue, Price and Gross (2018-2023)

    • Table Baxter Company Profile

    • Table Baxter Plague Revenue, Price and Gross (2018-2023)

    • Table Basilea Pharmaceutica Company Profile

    • Table Basilea Pharmaceutica Plague Revenue, Price and Gross (2018-2023)

    • Table Astellas Pharma Company Profile

    • Table Astellas Pharma Plague Revenue, Price and Gross (2018-2023)

    • Table Aspen Pharmacare Company Profile

    • Table Aspen Pharmacare Plague Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Profile

    • Table Bristol-Myers Squibb Plague Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Plague Revenue, Price and Gross (2018-2023)

    • Table Cipher Pharmaceuticals Company Profile

    • Table Cipher Pharmaceuticals Plague Revenue, Price and Gross (2018-2023)

    • Table Chiesi Farmaceutici Company Profile

    • Table Chiesi Farmaceutici Plague Revenue, Price and Gross (2018-2023)

    • Table CordenPharma Company Profile

    • Table CordenPharma Plague Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Plague Revenue, Price and Gross (2018-2023)

    • Table Cempra Company Profile

    • Table Cempra Plague Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.